Growth Hormone Secretagogue / GHRH Peptide Therapy

Evidence

These peptides reliably raise GH/IGF-1 biochemically, but there is no credible human trial evidence they yield the marketed anti-aging or longevity outcomes, and higher IGF-1 is associated in some data with increased cancer risk.

Regulatory notes

European Union

Not authorised by the EMA/AEMPS for anti-aging use; unlicensed compounded peptides are effectively prohibited outside approved indications in Spain and most EU states.

United States

Not FDA-approved for anti-aging; sermorelin, ipamorelin and CJC-1295 were removed from/left off the compounding-eligible list and are prescription-only at best in a regulatory gray zone.

United Arab Emirates

Unregistered GH-secretagogue peptides are not permitted; only MoHAP-registered products may be prescribed by DHA/DoH-licensed physicians.

United Kingdom

Not MHRA-licensed for human use; also prohibited in sport under WADA rules.

General information, not medical or legal advice. See our disclaimer.

Also known as

GH secretagogues, growth hormone peptides, GHRH peptides, sermorelin, sermorelin acetate, Geref, GRF 1-29, ipamorelin, CJC-1295, CJC1295, CJC 1295, CJC-1295 DAC, modified GRF 1-29, CJC/ipa, GHRP + GHRH stack, GHRP-6, GHRP-2, peptide GH therapy

Where to find it

40 clinics in the directory offer growth hormone secretagogue / ghrh peptide therapy. Prices shown are the cheapest for this treatment where published; always confirm with the venue.